Experts (National Institute of Oncology): Difference between revisions
From Beacon
No edit summary |
|||
| Line 28: | Line 28: | ||
=== Drug Therapy Center === | === Drug Therapy Center === | ||
'''[https://onkol.hu/ | '''[https://onkol.hu/kuraszeru-ellato-reszleg/ Curative Care Department]''' | ||
'''[https://onkol.hu/ | '''[https://onkol.hu/dermatoonkologiai-osztaly-kemoterapia-d/ Dermato-Oncology Departmente (Chemotherapy D)]''' | ||
'''[https://onkol.hu/hematologiai-es-lymphoma-osztaly-kemoterapia-a/ Hematology and Lymphoma (Chemotherapy A)]''' | |||
'''[https://onkol.hu/rehabilitacios-osztaly/ Rehabilitation Department]''' | '''[https://onkol.hu/rehabilitacios-osztaly/ Rehabilitation Department]''' | ||
'''[https://onkol.hu/ | '''[https://onkol.hu/mellkasi-es-hasuregi-daganatok-es-klinikai-farmakologiai-osztaly-kemoterapia-b/ Thoracic and Abdominal Tumors and Department of Clinical Pharmacology (Chemotherapy B)]''' | ||
'''[https://onkol.hu/ | '''[https://onkol.hu/urogenitalis-tumorok-es-klinikai-farmakologiai-osztaly-kemotarapia-c/ Urogenital Tumors and Department of Clinical Pharmacology (Chemotherapy C)]''' | ||
Revision as of 19:23, 16 May 2024
Go back to National Institute of Oncology page
Departments
Anesthesiology and Intensive Care
Breast - Soft Tissue Tumor Surgery
Oncology Imaging and Invasive Diagnostic Center
Drug Therapy Center
Dermato-Oncology Departmente (Chemotherapy D)
Hematology and Lymphoma (Chemotherapy A)
Thoracic and Abdominal Tumors and Department of Clinical Pharmacology (Chemotherapy B)
Urogenital Tumors and Department of Clinical Pharmacology (Chemotherapy C)
